Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Powderly, John, Cote, Gregory, Flaherty, Keith, Szmulewitz, Russell Z, Ribas, Antoni, Weber, Jeffrey, Loo, Deryk, Baughman, Jan, Chen, Francine, Moore, Paul, Bonvini, Ezio, Vasselli, James, Wigginton, Jon, Cohen, Roger, Burris, Howard, Chmielowski, Bartosz
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Oral Presentation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4645418/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-O8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars